Answers are grounded in this paper and cite their sources.
Oncolytic virotherapy (OVT) is a promising cancer treatment in which oncolytic viruses (OVs) act as immunostimulatory agents and selectively replicate and lyse tumor cells without harming normal tissues.1 OVs not only directly kill cancer cells but also boost anticancer systemic immunity. Genetic engineering of OVs can enhance their efficacy by including transgenes encoding cytokines, such as granulocyte-macrophage colony-stimulating factor (GM-CSF), interferons (IFNs), tumor necrosis factor (TNF), and interleukins (ILs).
No takes yet. Share an insight, caveat, or question.
Yoo et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: